重组人氧化型低密度脂蛋白受体1(OLR1)

特别提示：包括重组人氧化型低密度脂蛋白受体1(OLR1)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人氧化型低密度脂蛋白受体1(OLR1)
英文名称：Recombinant Human Oxidized Low-Density Lipoprotein Receptor 1
产品货号：JN0607
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Ser61-Gln273在C端含有His标签。

OLR1质量控制：＞95%(还原性SDS-PAGE)

OLR1制剂：冻干品

OLR1保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

OLR1复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于OLR1：
Oxidized Low-Density Lipoprotein Receptor 1 (Ox-LDL Receptor 1) is a secreted, single-pass type II membrane protein which belongs to the C-type lectin superfamily. Ox-LDL Receptor 1 is expressed at high levels in endothelial cells and vascular-rich organs such as placenta, lung, liver, brain, aortic intima, bone marrow, spinal cord and substantia nigra. The expression of Ox-LDL Receptor 1 is induced by inflammatory cytokines such as TNF, IFNG and IL6 by pathological conditions, such as hyperlipidemia, hypertension and diabetes mellitus. Ox-LDL Receptor 1 mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (OxLDL) by vascular endothelial cells. Ox-LDL Receptor 1 association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular responses including a reduction of nitric oxide (NO) release, monocyte adhesion and apoptosis. Ox-LDL Receptor 1 also binds to oxLDL, which acts as a receptor for the HSP70 protein involved in antigen cross-presentation to naive T-cells in dendritic cells, thereby participating in cell-mediated antigen cross-presentation. It also participates in inflammatory process, by acting as a leukocyte-adhesion molecule at the vascular interface in endotoxin-induced inflammation.

除了重组人氧化型低密度脂蛋白受体1(OLR1),，我公司还供应以下相关产品：


JN0389 重组小鼠白介素IL-36α(白细胞介素36α) 10μg|50μg|500μg|1mg
JN0426 重组小鼠干扰素γ(IFN-γ) 10μg|50μg|500μg|1mg
JN0429 重组人干扰素γ(哺乳动物细胞表达) 10μg|50μg|500μg|1mg
JN1899 重组人白血病抑制因子(LIF) 10μg|50μg|500μg|1mg
JN0595 重组人TREM-1 10μg|50μg|500μg|1mg
JN0762 重组人NTNG1(轴突导向因子G1)(神经突起生长导向因子G1)(神经突起生长诱向因子G1) 10μg|50μg|500μg|1mg
JN0769 重组人PACSIN2(神经元蛋白激酶C酪蛋白激酶底物2) 10μg|50μg|500μg|1mg
JN0923 重组人DNA片断化因子α(DFFA)(DNA断裂因子α) 10μg|50μg|500μg|1mg
JN1018 重组人Caspase14(CASP14) 10μg|50μg|500μg|1mg
JN1216 重组人RPS7(40S核糖体蛋白S7) 10μg|50μg|500μg|1mg
JN1344 重组小鼠HCFC2 10μg|50μg|500μg|1mg
JN1359 重组小鼠脂肪组织特异分泌因子(Resistin)(RETN) 10μg|50μg|500μg|1mg
JN1485 重组人B7-H1(PD-L1) 10μg|50μg|500μg|1mg
JN1553 重组人KIR2DL3 10μg|50μg|500μg|1mg
JN1581 重组人Mesothelin(间皮蛋白) 10μg|50μg|500μg|1mg
JN1681 重组人MMP-2(基质金属蛋白酶2) 10μg|50μg|500μg|1mg
JN1895 重组小鼠PD-1(程序化细胞死亡蛋白1) 10μg|50μg|500μg|1mg
ZN1565 人BAFFR重组蛋白 100ng